ahsct vs. high-activity dmts in ms treatment
Published 9 months ago • 307 plays • Length 7:36Download video MP4
Download video MP3
Similar videos
-
1:44
guidelines for ahsct in ms
-
2:12
early initiation of high-efficacy dmts in ms
-
3:49
ahsct in multiple sclerosis
-
0:47
when to make a timely switch to high-efficacy dmt for ms
-
1:03
future studies on ahsct for multiple sclerosis
-
2:13
repositioning hsct in the ms treatment algorithm
-
2:11
when should dmts be stopped when treating ms?
-
1:51
safety and efficacy of ahsct for ms
-
46:14
the case for offering ahsct as a first-line treatment for ms
-
2:57
initial high-efficacy disease-modifying therapy in multiple sclerosis
-
34:00
professor basil sharrack and professor john snowden - ahsct and the management of ms
-
8:45
what role does autologous haematopoietic stem cell transplant (ahsct) play in ms treatment?
-
44:42
multiple sclerosis webinar: a deep dive into dmts
-
40:44
harnessing the full potential of dmt mechanisms of action to improve ms outcomes
-
31:37
highly effective disease-modifying therapies for multiple sclerosis
-
2:06
challenges with stem cell therapy in ms
-
3:30
how do i choose an ms treatment? | decisions